NasdaqGM - Delayed Quote USD
89bio, Inc. (ETNB)
10.25
+0.29
+(2.91%)
At close: June 6 at 4:00:01 PM EDT
10.25
0.00
(0.00%)
After hours: June 6 at 6:15:25 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| LAPORTE KATHLEEN D Director | Sale | Jul 17, 2023 | 0 |
| LE-NGUYEN QUOC Chief Operating Officer | Sale | Apr 15, 2025 | 343,073 |
| MANSBACH HARRY H Officer | Stock Award(Grant) | Jan 31, 2025 | 323,701 |
| MARTINS RYAN Chief Financial Officer | Stock Award(Grant) | Jan 31, 2025 | 274,282 |
| MCWHERTER CHARLES A Director | Purchase | Jan 22, 2025 | 25,000 |
| PALEKAR ROHAN Chief Executive Officer | Stock Award(Grant) | Jan 31, 2025 | 873,638 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 30, 2025 | -- |
| SARENA FRANCIS WILLARD Chief Operating Officer | Stock Award(Grant) | Jan 31, 2025 | 78,750 |
Related Tickers
AKRO Akero Therapeutics, Inc.
54.28
+0.63%
MLYS Mineralys Therapeutics, Inc.
16.12
+3.20%
STOK Stoke Therapeutics, Inc.
11.14
+2.39%
DNLI Denali Therapeutics Inc.
14.70
+3.38%
NRIX Nurix Therapeutics, Inc.
12.78
+2.24%
BCAX Bicara Therapeutics Inc.
11.50
+4.26%
CNTA Centessa Pharmaceuticals plc
11.92
+0.51%
RLAY Relay Therapeutics, Inc.
3.3600
+3.70%
MDGL Madrigal Pharmaceuticals, Inc.
278.23
+1.51%
DYN Dyne Therapeutics, Inc.
14.70
+5.08%